b3c newswire Press Releases - EIN Presswire - Press Release Distribution Service

Published on December 8, 2020 - 14:12 GMT

SeraNovo Appoints Michiel Van Speybroeck as Chief Development Officer as Lead Programs Progress Through Clinical Studies

LEIDEN, The Netherlands, December 08, 2020 / B3C newswire / -- SeraNovo, a pharmaceutical company with a breakthrough proprietary formulation platform for enhancing drug bioavailability has appointed Dr Michiel Van Speybroeck to the role of Chief …

Distribution channels: Technology

Published on December 8, 2020 - 12:37 GMT

HALIX Signs Agreement with AstraZeneca for Commercial Manufacture of COVID-19 Vaccine

HALIX to provide large-scale GMP manufacture of AZD1222 LEIDEN, The Netherlands, December 08, 2020 / B3C newswire / -- HALIX B.V. signed an agreement with AstraZeneca AB for large-scale commercial drug substance manufacture of AZD1222, the adenovirus …

Distribution channels: Technology

Published on December 8, 2020 - 09:25 GMT

BioMed X Institute Completes First Research Project in Neuroscience with Boehringer Ingelheim

Research Team BMP (Brain Microcircuits in Psychiatric Diseases) uncovered alterations in astrocyte metabolism as a major hallmark of depression The completion of this project marks another milestone in the successful partnership with Boehringer Ingelheim …

Distribution channels: Technology

Published on December 8, 2020 - 08:18 GMT

RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology

BERN, Switzerland, December 08, 2020 / B3C newswire / -- RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in …

Distribution channels: Technology

Published on December 8, 2020 - 08:18 GMT

osteolabs GmbH Successfully Closes Second Financing Round of Nearly 1.6 Million EUR

Financial resources are used for further expansion of the company KIEL, Germany, December 08, 2020 / B3C newswire / -- osteolabs GmbH today announces the successful conclusion of a second financing round in the amount of approximately EUR 1.6 million. The …

Distribution channels: Technology

Published on December 3, 2020 - 15:18 GMT

Vetter Continues to Implement its Long-Term Sustainability Strategy

Minister of Transport praises the commitment of the pharmaceutical service provider during global turbulent times Support of environmentally friendly mobility concepts Use of green technologies at all German Vetter sites Carbon dioxide neutrality and …

Distribution channels: Technology

Published on November 30, 2020 - 08:17 GMT

Fire Monkey v8 HMW DNA Extraction Delivers 30Gb+ Yield from Sequencing on the ONT MinION

Increased yield can drive disposable costs for MinION to $35/Gb and for PacBio to <$10/Gb Fire Monkey version 8 (FMv8) record-breaking 30Gb+ yield of raw DNA data from an E. Coli sample on a single Oxford Nanopore Technologies (ONT) MinION flow cell ( …

Distribution channels: Technology

Published on November 23, 2020 - 13:27 GMT

Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP Manufacturing Agreement for MB-107 Lentiviral Gene ...

WORCESTER, Mass., USA and MUNICH, Germany, November 23, 2020 / B3C newswire / -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into …

Distribution channels: Technology

Published on November 20, 2020 - 14:10 GMT

Marinomed Biotech Plans Clinical Trial with Carragelose Nasal Spray to Investigate Prevention of COVID-19 Infection in Frontline ...

First Austrian SARS-CoV-2 prophylactic treatment to be tested in 334 individuals at two clinical sites in Vienna, Austria VIENNA, Austria, November 20, 2020 / B3C newswire / -- Marinomed Biotech AG (VSE:MARI), a globally operating biopharmaceutical company …

Distribution channels: Technology

Published on November 19, 2020 - 09:45 GMT

COVID-19: Treatment for the Most Severely Affected Patients - After Promising Results in Named Patient Use - Clinical Trial with ...

VIENNA, Austria, November 19, 2020 / B3C newswire / -- F4 Pharma, a clinical-stage biopharmaceutical company developing FX06, an anti-inflammatory therapeutic that has shown to improve vascular integrity, announces today the inclusion of the first patient …

Distribution channels: Technology

Published on November 18, 2020 - 13:02 GMT

Asahi Kasei Pharma Contracts ProBioGen for the Advancement of their Biologics Pipeline

BERLIN, Germany, November 18, 2020 / B3C newswire / -- ProBioGen AG announced the closing of a master service agreement with Asahi Kasei Pharma. As an expert CDMO in high-titer cell line development till large scale GMP manufacturing, ProBioGen will use …

Distribution channels: Technology

Published on November 18, 2020 - 08:25 GMT

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

BV100 is being developed for the treatment of serious hospital infections caused by Carbapenem resistant Acinetobacter baumannii BASEL, Switzerland, November 18, 2020 / B3C newswire / -- BioVersys has reached a major milestone by entering clinical …

Distribution channels: Technology

Published on November 16, 2020 - 09:11 GMT

Calypso Biotech Announces Successful Dosing of First Phase 1 Cohort with Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 ...

Dose-escalation study to evaluate safety, biological and early clinical effect of CALY-002 in healthy volunteers and patients with Celiac Disease and Eosinophilic Esophagitis AMSTERDAM, The Netherlands, November 16, 2020 / B3C newswire / -- Calypso Biotech …

Distribution channels: Technology

Published on November 16, 2020 - 08:10 GMT

Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune ...

R&D collaboration building on Lead Pharma’s expertise in the discovery, design and optimization of small molecule treatments Lead Pharma may receive payments of up to €260 million plus royalties on sales OSS, The Netherlands, November 16, 2020 / B3C …

Distribution channels: Technology

Published on November 12, 2020 - 08:15 GMT

Byondis to Present at the Jefferies 2020 Virtual Healthcare Conference

NIJMEGEN, The Netherlands, November 12, 2020 / B3C newswire / -- Byondis today announced that its Chief Executive Officer, Marco Timmers, Ph.D., will present at the Jefferies 2020 Virtual Healthcare Conference at 09.05 AM EST / 3:05 PM Central European …

Distribution channels: Technology

Published on November 11, 2020 - 14:40 GMT

SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020

Late breaking poster demonstrates SO-C101 was well tolerated to date with no dose-limiting toxicities Confirmed partial response was observed after SO-C101 monotherapy in a patient with skin squamous cell carcinoma PRAGUE, Czech Republic, November 11, 2020 …

Distribution channels: Technology

Published on November 9, 2020 - 09:16 GMT

BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research

New crowdsourcing project will examine the role of ‘Protective Tissue Factors in Autoimmune Diseases’ Call for application for this research program to open now HEIDELBERG, Germany, November 09, 2020 / B3C newswire / -- German independent research …

Distribution channels: Technology

Published on November 5, 2020 - 11:31 GMT

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences

LEIDEN, the Netherlands, November 05, 2020 / B3C newswire / -- ProteoNic, a leading provider of technology and services for efficient production of biologics, today announced it has licensed its premium 2G UNic™ technology for boosting therapeutic protein …

Distribution channels: Technology

Published on November 4, 2020 - 14:20 GMT

SOTIO to Present New Data on the IL-15 Superagonist SO-C101 at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

SOTIO will present three posters, including a late breaking poster on the clinical data from the ongoing Phase 1 study of IL-15 superagonist SO-C101 for the treatment of advanced solid tumors PRAGUE, Czech Republic, November 04, 2020 / B3C newswire / -- …

Distribution channels: Technology

Published on November 4, 2020 - 08:06 GMT

Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure Showing Functional Reversal and Myocardial ...

NIJMEGEN, The Netherlands, November 04, 2020 / B3C newswire / -- Saillant Therapeutics, an innovative preclinical stage biotechnology company developing promising small molecule-based therapies, today announced that it has obtained Proof of Concept for its …

Distribution channels: Technology